{"name":"Kyowa Kirin Korea Co., Ltd.","slug":"kyowa-kirin-korea-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AMG531","genericName":"AMG531","slug":"amg531","indication":"Thrombocytopenia","status":"phase_2"}]}],"pipeline":[{"name":"AMG531","genericName":"AMG531","slug":"amg531","phase":"phase_2","mechanism":"AMG531 is a thrombopoietin receptor agonist.","indications":["Thrombocytopenia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZGFDeEtITEVMQXV0ZHczcEx1NW4ybWx5X1BLNE1ZaGM1YXZJcjhaVXQ0S0Q1OEhBNW9PVkRkbUlQV3VYeW9ybHlTWnBaN2dKMkVXNF9iUFdzUnphSEJCODZzc2ZzenAzazRTWDdvRWg5OW9jR0FUWDA1WU5VcWxvNEY0N1Z0MjB1RFdrNko2dUplVDhJMHgzRXRPbmtBSmQ0QVJJMTY2cFhMZFNGMno4M2t1WHllRzEtY3FVZU9qSjlvREdjVmJTaEFZRnVYQTVmRWk3Y3FMSVlxM2VQ?oc=5","date":"2026-03-04","type":"pipeline","source":"prnewswire.com","summary":"Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight - prnewswire.com","headline":"Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOMEJUelhiaWlvS2t4eTB6Z2MwaXhsc1RkaUd6U2RxemhzbFRFV1lCM0J0TGFMOU05SGxnYjdDOURiQ011QTlBYjdVeGl6Rkk2Tnl5Y001SWF0RDFxSnN2ckQzOU1SQlFLbTZrRFUtVWF3Q2xZaGVrbWtCSGhPZXpqOXM4ZmdpZ1ZzeDRZZDNNNXFuVnJIcUZYZVV3ZVhZQU41b0l1OTFxS2NySlRkUEpXSUtVSHNJQkZsblZHcy05Q0xQZ3RubW1sUmMtQ2pjdw?oc=5","date":"2025-12-12","type":"pipeline","source":"BioSpectrum Asia","summary":"Japan's Kyowa Kirin names Dr Abdul Mullick as President and Chief Executive Officer - BioSpectrum Asia","headline":"Japan's Kyowa Kirin names Dr Abdul Mullick as President and Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5nbnJxZWxwX1Nrd0dLSW8zdHVzODNzMjdpZmF2RWJNdW1Ecnl3bmlpTHd0UEtaS2VJdHI4YmFRM1dsNEMxUmxzSVBEYWVBQTA1cHJ4ZnZ6UlJXM1RONXZ5U2YyUF84ZEVjLU5MNXFn0gFyQVVfeXFMTnVnS0xPT21fTzh2TDJXYl9zcUlmRzBDdEZrd3d3cURNSkFEYko5czNhYlJwUHhJRmQyWlRONkNBU2hwWnFPYXNiOWQ1MTNyTWVNNEtyMEZESWlTT1hhWTAtQjN5Z2x0ZXdTWndrUXY5ejZB?oc=5","date":"2025-04-18","type":"deal","source":"koreabiomed.com","summary":"DKSH Healthcare Korea eyes growth as flexible and capable partner: GM - koreabiomed.com","headline":"DKSH Healthcare Korea eyes growth as flexible and capable partner: GM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPMS1HMXJOQkZRSFBVaGJxcWJmQVVjM1dadlVnSjAzNTBXdW5Tei1KUFNCNUZMc0NBemFtY1VJdjNzUmlXeGpMbmw0eFJzaGx2MFRkQ2l4RElOUGl2MnBPWFhBc2JSYWRuR244SkpTWF9Tdk13NkZtNGxWWEc4cVFESWxZcElqb0hNMUxjMnQ2RlFYYmNIRTA2R0xKZ0lFOS03NGNsZ092Sk4yc0M3VU5LMExldG1oUmVFRHBBZFY2T0dsajZ1?oc=5","date":"2025-04-11","type":"pipeline","source":"Fierce Pharma","summary":"As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan - Fierce Pharma","headline":"As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHaUwteHZ4STgxaEpMWWRKT3I2ZE1sSFRMZWJYdm1aUG1TS3VVbFBxWUZKV05xRHBxRzc0U25WLURIVVZyZFdfaHUzYlV6Ym5KMDdaWUh4NXpRQlUzOWFB?oc=5","date":"2025-02-17","type":"trial","source":"Nature","summary":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia - Nature","headline":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPTEEzWTdwZG9TcW9oNzMzQVRveUJIUWI3UHFfQ3FBeWczbFN0eTNoLWM0Z3hTeVItWUFxN2NRNFNzaldKMmJvMXNjYUFvMld5T1hLdDNsYjVwTmVkaENIeHdXTlVfdjV5eVlkdjZqRVhxXzd6elBXaTZhTlVVR05ENGE5enRvYU5pcGFoUFZDTDlrNThyazJ2S1dmeTVuc2lvT3R4N2hjeW12WVEyaERoRTdWY0Q2Vl8tNVpoY0tUazZURnZ3akwxNA?oc=5","date":"2025-01-21","type":"pipeline","source":"Citeline News & Insights","summary":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","headline":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOWlhSVmttazNRR25CQVFzMlQtc0U4aktmLXFsX1Y2MjAxMkxLM1hMSW5nZTBZeGJ1el8yYlpEaG5rV1JKRWdyY29RWjZMYTFKTy1vcTBzb2dZa25Tc01wX0hlVC1wd194eFRkbGswd0xIdzFJV19mYUJpYzg2dXJKZU5jUV9Iem42SmQyRUFYcnUxSnBYbHc?oc=5","date":"2024-10-07","type":"trial","source":"EY","summary":"Case study: How a unified tax compliance approach generates value - EY","headline":"Case study: How a unified tax compliance approach generates value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWHhmT3JXaFZGYU1ZeFRkT3VWeFd2U2pZTWg1RmtwbHk1NWMzcTdaQzBjUDMxQzJJemJVd19CaWdzSUNOd0Y3S2s2ci1NOEVOaTVVMS1KMVl1WU9LQUlHdmNBOVppbWp5a0hESE9XMHBCVWR1eEh0U3ZqdjkzX1FTcGV5Z3AwMXhUM3pFb0daMGZNODNDRV95d2tHc2VnTWY4UjUxbmM2ak9wMVQ4SVJNSGYzSTNsOXJpS1loZEphdjc5dmt6ZFI4RGVERkFwTndQc3F6Z092MGdLSWtON2hjUk5ITko5UQ?oc=5","date":"2024-08-01","type":"pipeline","source":"prnewswire.com","summary":"Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region - prnewswire.com","headline":"Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOQ2daWGdsOGFsUkRCUXZibmNyWnBtV3BCQW9zOHhrLWh5dDM1OHBVU2ZzRHBZcUI5VE9DVWwtZnZBUkVUTUdQbXd4YUs4VUd2MFhKdVNYQ0pocWh5Z1BGWEhnejl2ZnB3c0pmZG1iYUs4QXFkNUFrWUwwdXVLUDlGYlp4akJNdFk3NldvX1cwcWEtTVpjLVJ4Z1VFRlplVXhCcWk0T3dTNTJTZmlOWVFIaXJ1NFB1NWphVlItbw?oc=5","date":"2024-08-01","type":"pipeline","source":"Fierce Pharma","summary":"Kyowa Kirin looks to cut small molecule research and manufacturing jobs, slims down in Asia - Fierce Pharma","headline":"Kyowa Kirin looks to cut small molecule research and manufacturing jobs, slims down in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOVkpCNmwwWTVSbmp0V2FsTDh6TzBkVUUtQVdSUU9UZEkxVXN6VmNnc0o5RWtqQ1d2aTUxMlEyQnlrdGNiRFJlNlYzeG4wbm4zQ29uREwzd2lnbTZGcE5MZWxQeHM1Wmw3aHpfMklheTdjTjNudmE4MXIxd1p3VnJFclgwTzgwS2lsR25lS1otN1NwRGhZTVJBM05jYnh2SnppVTl2Vl9KX01HR1BkWjF3a210T0lGRE00ZUdNdUY4SGlJTUotWExXeVhubEI3Q1JzdXlOWWExMkVsOVlpMmdDdnl1UV93Rm5ZWC1PRWRBVll0dw?oc=5","date":"2024-06-10","type":"regulatory","source":"prnewswire.com","summary":"Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC - prnewswire.com","headline":"Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOUFJTF9pQjZkZHlEZm9lLS1NcnQ2eGRqbUhPMXVsalpHUHlLWGxFQWc0SEpDZ1hNQTVKODVKV2pEc3hwQ1FUS051NFhvbWF2LWQ2Ny1oTzh2clJLcFgzdGdhcF9LWDltLURfWWxpRE4wTm0xQ0UyWGNZcjVtT21vclY4R3Y2X3RvSXBsSVhxM29BTjQ3YllGMlpwN0V4a3J2ZlE0Mk5Da2U?oc=5","date":"2024-01-30","type":"deal","source":"BioWorld News","summary":"Travere licenses out rare kidney disease drug to Renalys in Asia - BioWorld News","headline":"Travere licenses out rare kidney disease drug to Renalys in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1qR0h5MEJMZG1YU1lOclozaHp4MVdQeVVVc0o4MjBKeXJ3UUlnQ1N1Z0hGaG9nTlFVRWtlazZLT1hzZzlhdjA0aXJPZE90b1VoR3JSaVI5NV9JMDBoXzgxZ2l4WVo1WXo4Ykp4MFZyUUdST0syZXVCZnZZYw?oc=5","date":"2023-06-05","type":"pipeline","source":"PharmaLive","summary":"Pharma people on the move: spring fling 2023 - PharmaLive","headline":"Pharma people on the move: spring fling 2023","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}